KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.88 Cr | ₹-2.56 Cr | ₹-1.98 Cr | ₹-1.51 Cr | ₹-1.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-2.88 Cr |
| Mar2024 | ₹-2.56 Cr |
| Mar2023 | ₹-1.98 Cr |
| Mar2022 | ₹-1.51 Cr |
| Mar2021 | ₹-1.28 Cr |
How is Deferred Tax Assets / Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.88 Cr | Negative | |
| Mar2024 | ₹-2.56 Cr | Negative | |
| Mar2023 | ₹-1.98 Cr | Negative | |
| Mar2022 | ₹-1.51 Cr | Negative | |
| Mar2021 | ₹-1.28 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹458.2 Cr | -4% | -19.3% | -25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -4% |
-19.3% |
-25.8% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses